Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Zentalis Pharmaceuticals (ZNTL) Shares Outstanding (Diluted Average) (2022 - 2025)

Zentalis Pharmaceuticals has reported Shares Outstanding (Diluted Average) over the past 4 years, most recently at $71.9 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Diluted Average) at $71.9 million for Q4 2025, up 1.11% from a year ago — trailing twelve months through Dec 2025 was $71.9 million (up 1.11% YoY), and the annual figure for FY2025 was $71.9 million, up 1.11%.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $71.9 million at Zentalis Pharmaceuticals, roughly flat from $71.9 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for ZNTL hit a ceiling of $71.9 million in Q3 2025 and a floor of $45.2 million in Q1 2022.
  • Median Shares Outstanding (Diluted Average) over the past 4 years was $68.2 million (2023), compared with a mean of $63.9 million.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): surged 31.02% in 2023 and later increased 0.68% in 2025.
  • Zentalis Pharmaceuticals' Shares Outstanding (Diluted Average) stood at $52.9 million in 2022, then increased by 23.75% to $65.4 million in 2023, then rose by 8.67% to $71.1 million in 2024, then grew by 1.11% to $71.9 million in 2025.
  • The last three reported values for Shares Outstanding (Diluted Average) were $71.9 million (Q4 2025), $71.9 million (Q3 2025), and $71.8 million (Q2 2025) per Business Quant data.